98094108 - GLPG

Information

• Trademark
• 98094108

• Source

• Serial Number

  98094108

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  July 20, 2023
  a year ago

• Transaction Date

  July 12, 2024
  7 months ago

• Status Date

  July 01, 2024
  8 months ago

• Published for Opposition Date

  October 03, 2023
  a year ago

• Location Date

  November 28, 2023
  a year ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  BERLIN, JUSTIN E

• Attorney Name

  Alexandra MacKay

  Law Office Assigned Location Code

  N70

• Owners

  • Galapagos N.V.

Case File Statements

• GS0051: pharmaceutical substances and preparations for human use, namely, for the treatment of inflammatory diseases, autoinflammation diseases, autoimmune diseases, proliferative diseases, cancer, skin diseases, cardiovascular diseases, anti-infectives, hepatitis B virus, osteoarthritis, rheumatoid arthritis, atopic dermatitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma; biopharmaceutical substances and preparations for human use, namely, for the treatment of inflammatory diseases, autoinflammation diseases, autoimmune diseases, proliferative diseases, cancer, skin diseases, cardiovascular diseases, anti-infectives, hepatitis B virus, osteoarthritis, rheumatoid arthritis, atopic dermatitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma
• GS0441: medical services; medical and pharmaceutical advisory and consultancy services; gene bank services
• GS0421: medical and scientific research services; industrial research services in the field of assay development, target discovery and validation, drug development, chimeric antigen receptor T-cell therapy, and medicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific research, namely, the examination and testing of genes; development, laboratory analysis, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis, and testing of medicaments; the development of clinical assays, cellular tests, testing kits, diagnostic kits, and companion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medical, pharmaceutical and biopharmaceutical fields and gathering of data to populate those databases via collection of medical, pharmaceutical, biopharmaceutical research and clinical trial data; gene bank services for research purposes

Case File Event Statements

• 7/24/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 8/20/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/21/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/26/2023 - a year ago

  4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/13/2023 - a year ago

  5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/3/2023 - a year ago

  6 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/3/2023 - a year ago

  7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/28/2023 - a year ago

  9 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 7/1/2024 - 8 months ago

  10 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 7/12/2024 - 7 months ago

  11 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 11/6/2023 - a year ago

  8 - ASSIGNED TO EXAMINER Type: DOCK